Lotus Pharm vs NaviFUS: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and NaviFUS (6872) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ NaviFUS

0%+4172%-92%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYNaviFUSYoY
Oct 2026NT$2.13 billion-22.5%NT$564,000-19.0%
Sep 2026NT$2.77 billion+128.0%NT$815,000+22.6%
Aug 2026NT$2.11 billion+81.7%NT$852,000-65.3%
Jul 2026NT$2.49 billion+3.9%NT$795,000+32.1%
Jun 2026NT$3.4 billion+225.5%NT$1.1 million-24.9%
May 2026NT$2.32 billion+105.8%NT$821,000-51.8%
Apr 2026NT$3.09 billion+19.9%NT$1.3 million+226.3%
Mar 2026NT$4.35 billion+173.6%NT$16.9 million+4,172.0%
Feb 2026NT$2.24 billion+131.5%NT$665,000+80.7%
Jan 2026NT$2.05 billion-5.5%NT$658,000+88.0%
Dec 2025NT$2.44 billion+66.9%NT$683,000-44.3%
Nov 2025NT$1.06 billion-0.2%NT$643,000+42.9%
Oct 2025NT$2.75 billion+46.0%NT$696,000-91.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16